Skip to main content

Table 1 Descriptive statistics for demographic and clinical variables in CBT-I participants (N = 122)

From: Recording and reporting of adverse events during a randomized controlled trial of cognitive behavioural therapy for insomnia (CBT-I) among cancer survivors

Demographic and Clinical Variables

N (%)

Mean (SD)

Age

 

60.3 (11.31)

 20–29

2 (2)

 

 30–39

4 (3)

 

 40–49

15 (12)

 

 50–59

29 (24)

 

 60–69

47 (39)

 

 70–79

20 (16)

 

 80–89

5 (4)

 

Gender

 Women

95 (77.9)

 

 Men

27 (22.1)

 

Race

 White

112 (91.8)

 

 Indigenous

5 (4.1)

 

 Black

1 (.8)

 

 West Indian

1 (.8)

 

 Multiracial

2 (1.7)

 

 Unspecified

1 (.8)

 

Years of education

 

15.92 (3.03)

Cancer type

 Breast

55 (45.1)

 

 Colon/Rectal

4 (3.3)

 

 Head/Neck

4 (3.3)

 

 Prostate

9 (7.3)

 

 Hematological

17 (13.9)

 

 Uterine

7 (5.7)

 

 Skin

9 (7.3)

 

 Other✝

17 (13.9)

 

 Multiple types

21 (17.2)

 

Anxiety**

 Pre-treatment

  No anxiety

41 (34)

 

  Borderline

33 (39)

 

  Anxiety

48 (39)

 

 Mid-treatment 

  No anxiety

67 (55)

 

  Borderline

27 (22)

 

  Anxiety

28 (23)

 

 Post-treatment

  No anxiety

73 (61)

 

  Borderline

24 (20)

 

  Anxiety

23 (19)

 

Depression**

 Pre-treatment 

  No depression

69 (57)

 

  Borderline

29 (24)

 

  Depression

24 (20)

 

 Mid-treatment 

  No depression

96 (79)

 

  Borderline

18 (15)

 

  Depression

8 (7)

 

 Post-treatment 

  No depression

104 (87)

 

  Borderline

14 (12)

 

  Depression

2 (2)

 
  1. ✝Other cancers indicated by participants included carcinoma, appendix, neuroendocrine tumor, blastoma on liver, tongue, thyroid, bladder, kidney, lymphatic, and ovarian cancers
  2. **Measured by the Hospital Anxiety and Depression Scale (Zigmond and Snaith 1983)